43. A Decade of Vascularized Lymph Node Transplant (VLNT) for the Treatment of Lymphedema: A Meta-analysis of Prospective Clinical Trials

43. A Decade of Vascularized Lymph Node Transplant (VLNT) for the Treatment of Lymphedema: A Meta-analysis of Prospective Clinical Trials

Bibliographic Details
Main Authors:	Tal Brown, BS, Stav Brown, MD, Michelle Coriddi, MD, Babak J. Mehrara, MD, Joseph H. Dayan, MD
Format:	Article
Language:	English
Published:	Wolters Kluwer 2023-04-01
Series:	Plastic and Reconstructive Surgery, Global Open
Online Access:	http://journals.lww.com/prsgo/fulltext/10.1097/01.GOX.0000934292.51809.d7

Similar Items

D30. Immediate Lymphatic Reconstruction (ILR) with Vascularized Lymph Node Transplant (VLNT)
by: Stav Brown, MD, et al.
Published: (2023-04-01)

SP47. Immediate Lymphatic Reconstruction (IlR) with Vascularized Lymph Node Transplant (VLNT)
by: Stav Brown, MD, et al.
Published: (2023-05-01)

2. LONG-TERM PROSPECTIVE SAFETY AND EFFICACY OF VASCULARIZED LYMPH NODE TRANSPLANT (VLNT)
by: Stav Brown, MD, et al.
Published: (2022-04-01)

QS33. Long-term Prospective Safety and Efficacy of Vascularized Lymph Node Transplant (VLNT)
by: Stav Brown, MD, et al.
Published: (2022-06-01)

74. Four Year Prospective Outcomes Following Vascularized Lymph Node Transplant (VLNT)
by: Stav Brown, MD, et al.
Published: (2024-04-01)

155. Lymphedema and Autoimmunity: Is There A Link?
by: Stav Brown, MD, et al.
Published: (2023-05-01)

The Association between Lymphedema and Autoimmunity: A Large Case Control Study
by: Stav Brown, MD, et al.
Published: (2023-10-01)

Immediate Lymphatic Reconstruction with Vascularized Omentum Lymph Node Transplant: Reducing the Risk of Both Painful Contracture and Lymphedema
by: Stav Brown, MD, et al.
Published: (2024-04-01)

D8. Lymphedema and Autoimmunity: Is There a Link?
by: Stav Brown, MD, et al.
Published: (2023-04-01)

Prospective, Longitudinal Study of the Natural History of Breast Cancer-related Lymphedema and Factors Predictive of Disease Progression
by: Stav Brown, MD, et al.
Published: (2023-10-01)

43. Prospective Analysis Of The Sensitivity And Specificity Of Patient Reported Outcome Measures (PROMS) For The Diagnosis Of Cancer-related Lymphedema
by: Stav Brown, MD, et al.
Published: (2024-05-01)

Doxycycline for the Treatment of Cancer-related Lymphedema
by: Stav Brown, MD, et al.
Published: (2022-10-01)

29. Natural History of Breast Cancer-related Lymphedema
by: Stav Brown, MD, et al.
Published: (2023-04-01)

The Role of Indocyanine Green (ICG) Lymphography as a Screening Tool for Early-stage Lymphedema: Sensitivity and Specificity Analysis
by: Stav Brown, MD, et al.
Published: (2022-10-01)

45. Predicting The Progression Of Cancer-related Lymphedema: A Prospective Study
by: Stav Brown, MD, et al.
Published: (2024-05-01)

Abstract 120: Lymph Node Transplantation Decreases Local Immunosuppression In Lymphedema
by: Catherine L. Ly, MD, et al.
Published: (2018-04-01)

Doxycycline for the treatment of breast cancer-related lymphedema
by: Stav Brown, et al.
Published: (2022-10-01)

Secondary Lymphedema: Autoimmune, Auto-inflammatory, or Both?
by: Adana Campbell, MD, et al.
Published: (2023-10-01)

154. Non-invasive Detection of Subclinical Skin Changes in Lymphedema: A Promising Screening Method for Early Stage Disease
by: Stav Brown, MD, et al.
Published: (2023-05-01)

T Cell Repertoire Diversity in Lymphedema: Investigating the Antigens Driving the T Cell Response
by: Adana-Christine Campbell, et al.
Published: (2022-10-01)

A Novel Method for Quantitative Analysis and Staging of Lymphatic Function Using Indocyanine Green (ICG) Lymphography
by: Stav Brown, MD, et al.
Published: (2022-10-01)

PC32. Non-invasive Detection of Subclinical Skin Changes in Lymphedema: A Promising Screening Method for Early Stage Disease
by: Stav Brown, MD, et al.
Published: (2023-04-01)

SP40. A Novel Method for Quantitative Analysis and Staging of Lymphatic Function Using Indocyanine Green (ICG) Lymphography
by: Stav Brown, MD, et al.
Published: (2023-05-01)

Deep Inferior Epigastric Artery Vascularized Lymph Node Transfer: A Simple and Safe Option for Lymphedema
by: Rachel Danforth, MD, et al.
Published: (2020-07-01)

Comparisons of Submental and Groin Vascularized Lymph Node Flaps Transfer for Breast Cancer-Related Lymphedema
by: Olivia A. Ho, MD, et al.
Published: (2018-12-01)

Dual Fluorescent Tracers for Surgical Guidance: Preventing Donor-site Lymphedema in Vascularized Lymph Node Transfer
by: Irene A. Chang, BA, et al.
Published: (2022-06-01)

148. Extravasated Lymph from Secondary Lymphedema Patients Increases Cellular Permeability and Decreases Lymphatic Endothelial Cell VEGFR3 Expression
by: Kevin Kuonqui, BA, et al.
Published: (2023-05-01)

D37. Commercial Insurance Rates and Coding for Lymphedema Procedures: The Current State of Confusion and Need for Consensus
by: Danielle H. Rochlin, MD, et al.
Published: (2023-04-01)

Vascularized lymph node transplantation successfully reverses lymphedema and maintains immunity in a rat lymphedema model
by: Ahmet Hamdi Sakarya, et al.
Published: (2022-09-01)

Prophylactic Lymphovenous Bypass at the Time of Axillary Lymph Node Dissection Decreases Rates of Lymphedema
by: Romina Deldar, MD, et al.
Published: (2023-06-01)

Dorsal Wrist Placement for Vascularized Submental Lymph Node Transfer Significantly Improves Breast Cancer–Related Lymphedema
by: Hattan A. Aljaaly, MD, FRCSC, et al.
Published: (2019-02-01)

Abstract: Comparing Outcomes Between Vascularized Lymph Node Transfer and Lymphovenous Anastomosis in the Treatment of Primary Lymphedema
by: Ming-Huei Cheng, MD, MBA, FACS, et al.
Published: (2017-09-01)

48. TOPICAL CAPTOPRIL: A PROMISING THERAPEUTIC AVENUE FOR LYMPHEDEMA TREATMENT
by: Stav Brown, MD, et al.
Published: (2022-04-01)

Lymph Node Transplantation Decreases Swelling and Restores Immune Responses in a Transgenic Model of Lymphedema.
by: Jung-Ju Huang, et al.
Published: (2016-01-01)

Lymphedema and sentinel lymph node mapping
by: Peng-Hui Wang
Published: (2025-01-01)

P117. DUAL FLUORESCENT TRACERS FOR REVERSE LYMPHATIC MAPPING AND SURGICAL GUIDANCE: PREVENTING DONOR SITE ASSOCIATED LYMPHEDEMA IN VASCULARIZED LYMPH NODE TRANSPLANT SURGERY
by: Irene A. Chang, BA, et al.
Published: (2022-04-01)

D18. Risk of Breast Cancer-Related Lymphedema: Development and Validation of a Clinically-Relevant, Patient-facing Prediction Model
by: Danielle H. Rochlin, MD, et al.
Published: (2023-04-01)

Angiomyomatous hamartoma of the inguinal lymph nodes with localized lymphedema presenting as a soft subcutaneous mass
by: Ryoma Honda, MD, et al.
Published: (2022-09-01)

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce the risk of developing cancer-related lymphedema following axillary lymph node dissection (ALND)
by: Stav Brown, et al.
Published: (2024-09-01)

Five-year Follow-up Outcome of Total Omental Lymph Node Flap Transfer in Primary Lymphedema Patient
by: Nutcha Yodrabum, MD, et al.
Published: (2023-01-01)